IL32 has a complex role in PCas, acting as a pro-tumor factor in metastatic disease by recruiting macrophages that promote tumor growth and metastasis through the CTSZ-TRA2A/IL-32/ITGA5 axis 58. This evidence concerns the gene TRA2A and metastatic neoplasm.